Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Belgium / NCT07756749
Recruiting Not applicable

Minimal ACCess Hernia InguinAlis Treatment of Hernia

NCT07756749 · tracked via the Priya Life Science Belgium tracker
Sponsor
Algemeen Ziekenhuis Maria Middelares
Phase
Not applicable
Started
2026-08-02
Last updated
2026-09-04

Condition(s) studied

Inguinal Hernia Repair

Investigational drug(s) / intervention(s)

single-port robotic suprapubic inguinal hernia repair

single-port robotic suprapubic inguinal hernia repair: single-port robotic suprapubic inguinal hernia repair

Study summary

Evaluation of the perioperative and patient reported outcomes of a new surgical technique: single-port robotic suprapubic inguinal hernia repair (SPIN procedure).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults with a primary inguinal hernia, either unilateral or bilateral Exclusion Criteria: * Recurrent inguinal hernia after preperitoneal repair * Irreducible scrotal hernia * Post-prostatectomy * Laparotomy in the lower abdomen * Pregnancy * Contra-indication for general anaesthesia

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
AZ Maria Middelares Ghent East-Flanders Recruiting

More Algemeen Ziekenhuis Maria Middelares trials in Belgium

Laparoscopic Groin Hernia Repair by a 3D ENDOLAP Visible Mesh With or Without LiquiBand Fix 8 Mesh Fixation Recruiting
Goal-directed Fluid Therapy During Deep Inferior Epigastric Perforator (DIEP) Free Flap Breast Reconstruction Recruiting
Rapid Move Following Outpatient Surgery: Safety and Patient Characteristics Starting soon
Robotic Single Port Combined Umbilical and Inguinal Hernia Repair Recruiting
Robotic Single Port Ventral Hernia Repair Recruiting

Other trials for the same condition

Robotic Single Port Combined Umbilical and Inguinal Hernia Repair Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07756749 on ClinicalTrials.gov ↗ ← All trials in Belgium